Dr Reddys Laboratories (RDY) Inventory Average (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Inventory Average of $824.0 million for Q1 2026, up 3.32% year-over-year from $797.5 million in Q1 2025, and up 3.32% quarter-over-quarter from $797.5 million in Q1 2025.
Dr Reddys Laboratories (RDY) Inventory Average (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Inventory Average history runs 17 years deep, the most recent figure standing at $824.0 million for Q1 2026.
- In Q1 2026, Inventory Average rose 3.32% year-over-year to $824.0 million; the TTM figure through Mar 2026 stood at $824.0 million (up 3.32% YoY), while the FY2026 annual figure was $824.0 million, up 3.32% from the prior year.
- Inventory Average for Q1 2026 stood at $824.0 million, up from $797.5 million in the prior quarter.
- The five-year high for Inventory Average was $824.0 million in Q1 2026, with the low at $616.0 million in Q2 2023.
- The 5-year median for Inventory Average is $701.0 million (2024), against an average of $717.9 million.
- The sharpest annual moves came in 2023 and 2025: Inventory Average decreased 5.38% in 2023, then gained 13.77% in 2025.
- Dr Reddys Laboratories' Inventory Average stood at $651.0 million in 2022, then decreased by 5.38% to $616.0 million in 2023, then climbed by 13.8% to $701.0 million in 2024, then increased by 13.77% to $797.5 million in 2025, then advanced by 3.32% to $824.0 million in 2026.
- Business Quant data shows RDY's Inventory Average at $824.0 million in Q1 2026, $797.5 million in Q1 2025, and $701.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 824.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 317.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 824.00 Mn |
| Mar 31, 2025 | 797.50 Mn |
| Mar 31, 2024 | 701.00 Mn |
| Jun 30, 2023 | 616.00 Mn |
| Jun 30, 2022 | 651.00 Mn |
| Mar 31, 2021 | 614.00 Mn |
| Dec 31, 2020 | 585.00 Mn |
| Mar 31, 2020 | 491.00 Mn |
| Dec 31, 2019 | 504.00 Mn |
| Mar 31, 2019 | 480.50 Mn |
| Jun 30, 2018 | 442.50 Mn |
| Mar 31, 2018 | 212.50 Mn |
| Dec 31, 2017 | 421.50 |
| Sep 30, 2017 | 217.50 Mn |
| Jun 17, 2017 | 438.00 Mn |
| Mar 17, 2017 | 220.50 Mn |
| Dec 31, 2016 | 431.00 |
| Sep 30, 2016 | 207.00 Mn |
| Dec 31, 2015 | 406.50 Mn |
| Sep 30, 2015 | 410.50 Mn |